Top compounds associated with response to BRD1


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 4e-08
mRNA PHA-793887 GDSC1000 pan-cancer AAC 0.16 5e-08
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.17 5e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 6e-08
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.21 9e-08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA BX-912 GDSC1000 pan-cancer AAC 0.17 1e-07
mRNA alisertib CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA CD-437 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC 0.16 3e-07
Download CSV